PlainPharmaWatch

CMS Open Payments · Tool

Varex Imaging Corporation vs PENTAX of America, Inc.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Varex Imaging Corporation has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 9,523, versus 642 for the other company. Its single largest recorded recipient represents 97.6% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Varex Imaging Corporation
HHI 9,523 · top recipient 97.6%
Ranked #153 of 1,838 companies by HHI
PENTAX of America, Inc.
HHI 642 · top recipient 15.5%
Ranked #1,202 of 1,838 companies by HHI

Payment Overview

Total Payments
$1.0M
% of Industry
0.0%
Transactions
69
Avg per Transaction
$14.8K
Recipients
68
Avg per Recipient
$15.1K
Payment Types
4
Top Payment Type
Compensation for Services Other Than Consulting
Total Payments
$1.0M
% of Industry
0.0%
Transactions
664
Avg per Transaction
$1.6K
Recipients
638
Avg per Recipient
$1.6K
Payment Types
7
Top Payment Type
Grant

Highlighted values indicate the higher figure for each metric.

Total payments compared

Varex Imaging Corporation vs PENTAX of America, Inc. - total reported payments in CMS Open Payments PY2024

PENTAX of America, Inc.$1.0MVarex Imaging Corporation$1.0M

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

Varex Imaging Corporation

Compensation for Services Other Than Consulting $89.8K

87.7%

Travel and Lodging $8.4K

8.2%

Consulting Fee $2.5K

2.4%

Food and Beverage $1.7K

1.6%

PENTAX of America, Inc.

Grant $136.9K

37.1%

Travel and Lodging $72.9K

19.8%

Long-Term Medical Supply or Device Loan $68.1K

18.4%

Consulting Fee $60.9K

16.5%

Food and Beverage $26.8K

7.3%

Compensation for Services Other Than Consulting $3.2K

0.9%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Varex Imaging Corporation

  1. 1

    Jocelyn D Chertoff

    $99,841.43 · 67 txns

  2. 2

    Sherwin Pollock

    $2,500.00 · 1 txns

PENTAX of America, Inc.

  1. 1

    Mayo Clinic Hospital

    $57,349.71 · 4 txns

  2. 2

    Cleveland Clinic Hospital

    $38,674.91 · 2 txns

  3. 3

    Mercy Hospital Of Buffalo

    $27,992.82 · 12 txns

  4. 4

    Resnick Neuropsychiatric Hospital At

    $27,804.19 · 1 txns

  5. 5

    SHELBY SULLIVAN

    $22,053.37 · 10 txns

Summary Comparison

Metric Varex Imaging Corporation PENTAX of America, Inc.
Total Payments $1.0M $1.0M
% of Industry Total 0.0% 0.0%
Transaction Count 69 664
Avg per Transaction $14.8K $1.6K
Recipient Count 68 638
Avg per Recipient $15.1K $1.6K
Payment Type Count 4 7
Top Payment Type Compensation for Services Other Than Consulting Grant

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.